Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor

Growth Hormone and IGF Research

Volumn 21, Issue 3, 2011, Pages 155-159

  Makimura, H ^a   Stanley, T L ^a   Chen, C Y ^a   Branch, K L ^a   Grinspoon, S K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adiponectin; Growth hormone; Growth hormone releasing hormone; Tesamorelin

Indexed keywords

ADIPONECTIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; TESAMORELIN;

ADULT; ARTICLE; BODY MASS; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; MALE; MOLECULAR WEIGHT; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE;

ADIPONECTIN; ADOLESCENT; ADULT; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; OBESITY;

EID: 79958126775     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2011.03.009     Document Type: Article

References (24)

1. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 1996, 271:10697-10703.
2. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
3. Faraj M., Havel P.J., Phelis S., Blank D., Sniderman A.D., Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J. Clin. Endocrinol. Metab. 2003, 88:1594-1602.
4. Iranmanesh A., Lizarralde G., Veldhuis J.D. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) ceretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 1991, 73:1081-1088.
5. Riedel M., Hoeft B., Blum W.F., von zur Muhlen A., Brabant G. Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction. Metabolism 1995, 44:605-610.
6. Bonert V.S., Elashoff J.D., Barnett P., Melmed S. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J. Clin. Endocrinol. Metab. 2004, 89:3397-3401.
7. Rasmussen M.H., Hvidberg A., Juul A., et al. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J. Clin. Endocrinol. Metab. 1995, 80:1407-1415.
8. Xu A., Wong L.C., Wang Y., Xu J.Y., Cooper G.J., Lam K.S. Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. FEBS Lett. 2004, 572:129-134.
9. Wolfing B., Neumeier M., Buechler C., Aslanidis C., Scholmerich J., Schaffler A. Interfering effects of insulin, growth hormone and glucose on adipokine secretion. Exp. Clin. Endocrinol. Diabetes 2008, 116:47-52.
10. Nilsson L., Binart N., Bohlooly Y.M., et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem. Biophys. Res. Commun. 2005, 331:1120-1126.
11. Lanes R., Soros A., Gunczler P., et al. Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins. J. Pediatr. 2006, 149:324-329.
12. Svensson J., Herlitz H., Lundberg P.A., Johannsson G. Adiponectin, leptin, and erythrocyte sodium/lithium countertransport activity, but not resistin, are related to glucose metabolism in growth hormone-deficient adults. J. Clin. Endocrinol. Metab. 2005, 90:2290-2296.
13. Fukuda I., Hizuka N., Ishikawa Y., et al. Serum adiponectin levels in adult growth hormone deficiency and acromegaly. Growth Horm. IGF Res. 2004, 14:449-454.
14. Makimura H., Stanley T., Mun D., et al. Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity. J. Clin. Endocrinol. Metab. 2009, 94:5131-5138.
15. Stanley T.L., Chen C.Y., Branch K.L., Makimura H., Grinspoon S.K. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. J. Clin. Endocrinol. Metab. 2010, 96:150-158.
16. Johnson M.L., Pipes L., Veldhuis P.P., et al. AutoDecon: a robust numerical method for the quantification of pulsatile events. Methods Enzymol. 2009, 454:367-404.
17. Festen D.A., van Toorenenbergen A., Duivenvoorden H.J., Hokken-Koelega A.C. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy. J. Clin. Endocrinol. Metab. 2007, 92:1549-1554.
18. Willemsen R.H., Mulder P.G., van Toorenenbergen A.W., Hokken-Koelega A.C. Long-term GH treatment is not associated with disadvantageous changes of inflammatory markers and adipocytokines in children born small for gestational age. Clin. Endocrinol. (Oxf.) 2008, 68:198-205.
19. Darendeliler F., Aycan Z., Cetinkaya E., et al. Effects of growth hormone on growth, insulin resistance and related hormones (ghrelin, leptin and adiponectin) in Turner syndrome. Horm. Res. 2007, 68:1-7.
20. Schmid C., Bianda T., Zwimpfer C., Zapf J., Wiesli P. Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels. Growth Horm. IGF Res. 2005, 15:300-303.
21. Kanety H., Hemi R., Ginsberg S., et al. Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. Eur. J. Endocrinol. 2009, 161:837-844.
22. Oliveira C.R.P., Salvatori R., Meneguz-Moreno R.A., et al. Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 2010, 95:693-698.
23. Psilopanagioti A., Papadaki H., Kranjoti E.F., Alexandrides T.K., Varakis J.N. Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 2009, 89:38-47.
24. Steyn F.J., Boehme F., Gargas E., et al. Adiponectin regulate growth hormone secretion via adiponectin receptor mediated Ca(2+) signaling in rat somatotrophs in vitro. J. Neuroendocrinol. 2009, 8:698-704.